Institute of Physiological Chemistry, Martin-Luther-University Halle-Wittenberg, D-06097, Halle, Germany.
Institute of Physiological Chemistry, Martin-Luther-University Halle-Wittenberg, D-06097, Halle, Germany.
Exp Eye Res. 2024 Jun;243:109888. doi: 10.1016/j.exer.2024.109888. Epub 2024 Apr 6.
Cataracts and Alzheimer's disease (AD) are closely linked and are associated with aging and with systemic diseases that increase the molar ratio of free fatty acids to albumin (mFAR) in the blood. From the results of our earlier studies on the development of senile cataracts and from results recently published in the literature on the pathogenesis of Alzheimer's disease, we suggest that there is a common lipotoxic cascade for both diseases, explaining the strong connection between aging, an elevated mFAR in the blood, cataract formation, and AD. Long-chain free fatty acids (FFA) are transported in the blood as FFA/albumin complexes. In young people, vascular albumin barriers in the eyes and brain, very similar in their structure and effect, reduce the FFA/albumin complex concentration from around 650 μmol/l in the blood to 1-3 μmol/l in the aqueous humour of the eyes as well as in the cerebrospinal fluid of the brain. At such low concentrations the fatty acid uptake of the target cells - lens epithelial and brain cells - rises with increasing FFA/albumin complex concentrations, especially when the fatty acid load of albumin molecules is mFAR>1. At higher albumin concentrations, for instance in blood plasma or the interstitial tissue spaces, the fatty acid uptake of the target cells becomes increasingly independent of the FFA/albumin complex concentration and is mainly a function of the mFAR (Richieri et al., 1993). In the blood plasma of young people, the mFAR is normally below 1.0. In people over 40 years old, aging increases the mFAR by decreasing the plasma concentration of albumin and enhancing the plasma concentrations of FFA. The increase in the mFAR in association with C6-unsaturated FFA are risk factors for the vascular albumin barriers (Hennig et al., 1984). Damage to the vascular albumin barrier in the eyes and brain increases the concentration of FFA/albumin complex in the aqueous humour as well as in the cerebrospinal fluid, leading to mitochondrial dysfunction and the death of lens epithelial and brain cells, the development of cataracts, and AD. An age-dependent increase in the concentration of FFA/albumin complex has been found in the aqueous humour of 177 cataract patients, correlating with the mitochondria-mediated apoptotic death of lens epithelial cells, lens opacification and cataracts (Iwig et al., 2004). Mitochondrial dysfunction is also an early crucial event in Alzheimer's pathology, closely connected with the generation of amyloid beta peptides (Leuner et al., 2012). Very recently, amyloid beta production has also been confirmed in the lenses of Alzheimer's patients, causing cataracts (Moncaster et al., 2022). In view of this, we propose that there is a common lipotoxic cascade for senile cataract formation and senile AD, initiated by aging and/or systemic diseases, leading to an mFAR>1 in the blood.
白内障和阿尔茨海默病(AD)密切相关,与衰老以及增加血液中游离脂肪酸与白蛋白摩尔比(mFAR)的系统性疾病有关。从我们之前关于老年白内障发展的研究结果以及最近关于 AD 发病机制的文献结果来看,我们认为这两种疾病存在共同的脂毒性级联反应,这解释了衰老、血液中升高的 mFAR、白内障形成和 AD 之间的强烈联系。长链游离脂肪酸(FFA)在血液中作为 FFA/白蛋白复合物运输。在年轻人中,眼睛和大脑中的血管白蛋白屏障在结构和功能上非常相似,将 FFA/白蛋白复合物的浓度从血液中的约 650 μmol/l 降低到眼睛的房水中以及大脑的脑脊液中 1-3 μmol/l。在如此低的浓度下,靶细胞 - 晶状体上皮细胞和脑细胞 - 的脂肪酸摄取随着 FFA/白蛋白复合物浓度的增加而增加,特别是当白蛋白分子的脂肪酸负荷 mFAR>1 时。在更高的白蛋白浓度下,例如在血浆或间质组织空间中,靶细胞的脂肪酸摄取越来越独立于 FFA/白蛋白复合物浓度,并且主要是 mFAR 的功能(Richieri 等人,1993 年)。在年轻人的血浆中,mFAR 通常低于 1.0。在 40 岁以上的人群中,衰老通过降低血浆白蛋白浓度和增加血浆 FFA 浓度来增加 mFAR。与 C6-不饱和 FFA 相关的 mFAR 增加是血管白蛋白屏障的危险因素(Hennig 等人,1984 年)。眼睛和大脑中的血管白蛋白屏障受损会增加房水和脑脊液中 FFA/白蛋白复合物的浓度,导致线粒体功能障碍和晶状体上皮细胞和脑细胞死亡、白内障和 AD 的发展。在 177 名白内障患者的房水中发现 FFA/白蛋白复合物浓度随年龄增长而增加,与晶状体上皮细胞的线粒体介导的凋亡死亡、晶状体混浊和白内障相关(Iwig 等人,2004 年)。线粒体功能障碍也是阿尔茨海默病病理的早期关键事件,与淀粉样β肽的产生密切相关(Leuner 等人,2012 年)。最近,也在阿尔茨海默病患者的晶状体中证实了淀粉样β肽的产生,导致白内障(Moncaster 等人,2022 年)。有鉴于此,我们提出,衰老和/或系统性疾病引发的老年白内障形成和老年 AD 存在共同的脂毒性级联反应,导致血液中的 mFAR>1。